From: End-stage renal disease preceded by rapid declines in kidney function: a case series
 | ESRD precipitated by ARF (N = 9) | ESRD not precipitated by ARF (N = 62) |
---|---|---|
Age at dialysis initiation (yrs) | 69.7 ± 10.5 | 67.3 ± 12.2 |
Male | 9 (100%) | 58 (93.5%) |
Race/Ethnicity, N (%) | Â | Â |
   White | 2 (22.2%) | 27 (43.5%) |
   Asian | 1 (11.1%) | 13 (20.9%) |
   Black | 6 (66.7%) | 22 (35.5%) |
   Hispanic | 0 | 0 |
Co-morbid conditions, N (%) | Â | Â |
   Hypertension | 9 (100%) | 56 (90.3%) |
   Diabetes mellitus | 5 (55.6%) | 35 (56.5%) |
   Congestive heart failure | 1 (11.1%) | 24 (38.7%) |
Initial renal replacement therapy modality, N (%) | Â | Â |
   Hemodialysis | 9 (100%) | 62 (100%) |
   Peritoneal dialysis (PD) | 0 | 0 |
Access for dialysis, N (%) | Â | Â |
   Hemodialysis catheter | 9 (100%) | 48 (77.4%)§ |
   Hemodialysis fistula | 0 | 12 (19.3%) |
   Hemodialysis graft | 0 | 2 (3.2%) |
   Peritoneal dialysis catheter | 0 | 0 |